Aspira Pathlab & Diagnostics informs about disclosure

02 Mar 2024 Evaluate

Aspira Pathlab & Diagnostics has informed that it enclosed the following disclosure Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from Nikunj Velji Mange (DIN: 08489442), Executive Director of the Company for the acquisition of Equity Shares from the market.

The above information is a part of company’s filings submitted to BSE.

Aspira Pathlab&Diagn Share Price

55.03 2.03 (3.83%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7036.65
Max Healthcare Inst 1006.75
Narayana Hrudayalay 1249.35
Aster DM Healthcare 444.55
Global Health 1115.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.